Therapeutic Uses of Gastrointestinal Peptides

1992, Effect of calcitoningene-related peptide in patients with delayed postoperative cerebral ischaemia after aneurysmal subarachnoid haemorrhage, Lancet, 339, 831 Ambinder, 1979, Endorphins: New gut peptides with a familiar face, Gastroenterology, 77, 1132, 10.1016/S0016-5085(79)80089-X Amir, 1984, Thyrotropin-releasing hormone (TRH) improves survival in anaphylactic shock: A central effect mediated by the sympatho-adrenomedullary β-adrenoceptive system, Brain Res, 298, 219, 10.1016/0006-8993(84)91421-5 Anderson, 1982, Epidural met-enkephalin (FK 33-824). A dose-effect study, Acta Anaesthesiol Scand, 26, 69, 10.1111/j.1399-6576.1982.tb01729.x Ballard, 1992, Respiratory disease in very low birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid, Lancet, 339, 510, 10.1016/0140-6736(92)90337-3 Barkan, 1989, Acromegaly, Endocrinol Metab Clin North Am, 18, 277, 10.1016/S0889-8529(18)30372-4 Battershill, 1989, Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion, Drugs, 38, 658, 10.2165/00003495-198938050-00002 Bayliss, 1902, Preliminary communication on the causation of the socalled “peripheral reflex secretion” of the pancreas, Lancet, 1, 813, 10.1016/S0140-6736(01)82072-9 Bloom, 1983, CCK-8 in the treatment of chronic schizophrenia, Psychopharmacol Bull, 19, 361 Bloomfield, 1983, Metkephamid and meperidine analgesia after episiotomy, Clin Pharmacol Ther, 34, 240, 10.1038/clpt.1983.160 Blum, 1983, Peptide neurotransmitters and their implications for the treatment of tardive dyskinesia, Mod Probl Pharmacopsychiatry, 21, 187, 10.1159/000408493 Brown, 1989, Enhancement of wound healing by topical treatment with epidermal growth factor, N Engl J Med, 321, 76, 10.1056/NEJM198907133210203 Brown, 1989, Gastric inhibitory polypeptide, 403 Burroughs, 1991, Somatostatin and octreotide in gastroenterology, Aliment Pharmacol Ther, 5, 331, 10.1111/j.1365-2036.1991.tb00036.x Calimlim JF, Wardell WM, Sriwatanakul K, et al: Analgesic efficacy of parenteral metkephamid acetate in treatment of postoperative pain. Lancet 1374–1375, 1982 Camisa, 1991, Somatostatin therapy, vol 2, 829 Cavagnini, 1992, Ineffectiveness of ceruletide to reduce food intake and body weight in obese women hospitalized for weight reduction and treated with a restricted diet. A double-blind study, Peptides, 8, 455, 10.1016/0196-9781(87)90009-X Cho, 1990, Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: Angiographic evaluation, Radiology, 177, 549, 10.1148/radiology.177.2.2171015 Coelle, 1983, Beneficial effect of pancreatic polypeptide in experimental pancreatitis, Dig Dis Sei, 28, 1083, 10.1007/BF01295806 Cook, 1988, Somatostatin treatment for cryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 108, 708, 10.7326/0003-4819-108-5-708 Cooper, 1991, Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus, Med Hypotheses, 36, 284, 10.1016/0306-9877(91)90150-W Doppman, 1990, Gastrinomas: Localization by means of selective intraarterial injection of secretin, Radiology, 174, 25, 10.1148/radiology.174.1.2294556 Drumm, 1988, Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy, Lancet, 1, 111, 10.1016/S0140-6736(88)90303-0 Dunne, 1987, Sandostatin and gastroenteropancreatic endocrine tumors-therapeutic characteristics, 93 Dupre, 1973, Stimulation of insulin secretion by gastric inhibitory polypeptide in man, J Clin Endocrinol Metab, 37, 826, 10.1210/jcem-37-5-826 Faden, 1983, Neuropeptides and stroke: Current status and potential application, Stroke, 14, 169, 10.1161/01.STR.14.2.169 Faden, 1985, Jacobs TP: Effect of TRH analogs on neurologic recovery after experimental spinal trauma, Neurology, 35, 1331, 10.1212/WNL.35.9.1331 Faden, 1981, Endorphins in experimental spinal injury: Therapeutic effect of naloxone, Ann Neurol, 10, 326, 10.1002/ana.410100403 Faden, 1983, Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury, Neurology, 33, 673, 10.1212/WNL.33.6.673 Faden, 1992, Pharmacological strategies in CNS trauma, TIPS, 13, 29 Falanga, 1992, Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers, J Dermatol Surg Oncol, 18, 604, 10.1111/j.1524-4725.1992.tb03514.x Ferrari, 1991, Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure, Lancet, 338, 1084, 10.1016/0140-6736(91)91944-P Frederickson, 1986, Progress in the potential use of enkephalin analogs, NIDA Res Monogr, 70, 367 Fukumoto, 1989, A new therapeutic trial of secretin in the treatment of intrahepatic cholestasis, Gastroenterol Jpn, 24, 298, 10.1007/BF02774328 Glaser, 1988, Effects of secretin on the normal and pathologic beta bell, J Clin Endocrinol Metab, 66, 1138, 10.1210/jcem-66-6-1138 Gozes, 1992, A fatty neuropeptide. Potential drug for ininvasive impotence treatment in a rat model, J Clin Invest, 90, 810, 10.1172/JCI115955 Green, 1989, Gastrointestinal peptides, Gastroenterol Clin North Am, 18, 695, 10.1016/S0889-8553(21)00438-6 Griffiths, 1987, Clinical applications of thyrotrophin-releasing hormone, Clin Sei, 73, 449, 10.1042/cs0730449 Grosman, 1990, Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide, Am J Gastroenterol, 85, 1061 Guiloff, 1989, Use of TRH analogues in motomeurone disease, Ann NY Acad Sei, 553, 399, 10.1111/j.1749-6632.1989.tb46662.x Günnes, 1986, Haemodynamic effects of pharmacological doses of secretrin in patients with impaired left ventricular function, Eur Heart J, 7, 146, 10.1093/oxfordjournals.eurheartj.a062037 Hanko, 1985, Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries, Neurosci Lett, 57, 91, 10.1016/0304-3940(85)90045-X Hanoir, 1987, Management of medullary thyroid carcinomas, Acta Otorhinolaryngol Belg, 43, 782 Harris, 1990, Future medical prospects for Sandostatin, Z Gastroenterol, 28, 55 Hennessey, 1989, Growth factors and diabetic wound healing: Epidermal growth factor and insulin, Curr Surg, 46, 285 Higgins, 1987, Pharmacotherapy of circulatory shock, Dis Mon, 33, 309, 10.1016/0011-5029(87)90017-4 Hokfelt, 1980, Evidence for co-existence of dopamine and CCK in mesolimbic neurones, Nature, 285, 476, 10.1038/285476a0 Holaday, 1978, Thyrotrophin releasing hormone antagonizes β endorphin hypothermia and catalepsy, Life Sei, 22, 1537, 10.1016/0024-3205(78)90009-7 Hopman, 1988, Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995, Ann Surg, 207, 155, 10.1097/00000658-198802000-00007 Hoppenreijs, 1992, Effects of human epidermal growth factor on endothelial wound healing of human corneas, Invest Opthalmol Vis Sei, 33, 1946 Isenberg, 1972, Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome, Gastroenterology, 62, 626, 10.1016/S0016-5085(72)80048-9 Itoh, 1988, Experimental and clinical studies on epidermal growth factor for gastric mucosal protection and healing of gastric ulcers, J Clin Gastroenterol, 10, S7, 10.1097/00004836-198812001-00003 Jian, 1989, Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension, Chin Med J, 102, 897 Kandarakis, 1984, The effect of epidermal growth factor on epithelial healing after penetrating keratoplasty in human eyes, Am J Opthalmol, 98, 411, 10.1016/0002-9394(84)90121-1 Katz, 1989, Octreotide. A new somatostatin analogue, Clin Pharm, 8, 255 Katz, 1988, Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS, Drug Intell Clin Pharm, 22, 134, 10.1177/106002808802200206 Klein, 1981, Thyroid function studies in cord blood from premature infants with and without RDS, J Pediatr, 98, 818, 10.1016/S0022-3476(81)80856-6 Konturek, 1991, Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa, J Clin Gastroenterol, 13, S88, 10.1097/00004836-199112001-00015 Kvols, 1989, Therapy of the malignant carcinoid syndrome and metastatic islet cell carcinoma, 65 Lamberts, 1991, The role of somatostatin and its analogs in the diagnosis and treatment of tumors, Endocrine Rev, 12, 450, 10.1210/edrv-12-4-450 Lissoni, 1987, Synthetic enkephalin analog in the treatment of cancer chemotherapy-induced vomiting, Cancer Treat Rep, 71, 665 Long, 1986, Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats, Circ Shock, 18, 1 Maton, 1986, Successful therapy of pancreatic cholera with the long-acting somatostatin analogue SMS 201-995: Relation between plasma concentrations of drug and clinical and biochemical responses, Scand J Gastroenterol, 21, 181, 10.3109/00365528609087449 McGuigan, 1989, The Zollinger-Ellison syndrome, 909 Montgomery, 1988, The use of cholecystokinin in schizophrenia: A review, Psychol Med, 18, 593, 10.1017/S0033291700008278 Moody, 1985, Gastric inhibitory polypeptide (GIP): A therapeutic possibility?, Acta Paediatr Scand, 320, 66, 10.1111/j.1651-2227.1985.tb10141.x Morice, 1983, Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects, Lancet, 2, 1225, 10.1016/S0140-6736(83)91272-2 Morice, 1986, Vasoactive intestinal peptide as a bronchodilator in severe asthma, Peptides, 7, 279, 10.1016/0196-9781(86)90202-0 Munsat, 1992, Intrathecal thyrotropin-releasing hormone does not alter the progressive course of ALS: Experience with an intrathecal drug delivery system, Neurology, 42, 1049, 10.1212/WNL.42.5.1049 O’Dorisio, 1990, Somatostatin and somatostatin-like peptides: Clinical research and clinical applications, vol 1, 175 Ogawa, 1990, Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment, J Clin Invest, 85, 973, 10.1172/JCI114528 Ollerenshaw, 1989, Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma, N Engl J Med, 320, 1244, 10.1056/NEJM198905113201904 Palmer, 1986, Effect of infused vasoactive intestinal peptide on airway function in normal subjects, Thorax, 41, 663, 10.1136/thx.41.9.663 Paul, 1989, Catalytic hydrolysis of vasoactive intestinal peptide by human antibody, Science, 244, 1158, 10.1126/science.2727702 Peabody, 1986, Thyrotropin-releasing hormone (TRH) and Alzheimer’s disease, Am J Psychiatry, 143, 262, 10.1176/ajp.143.2.262b Peters, 1991, Thyrotropin-releasing hormone—a lactation-promoting agent?, Br J Obstet Gynaecol, 98, 880, 10.1111/j.1471-0528.1991.tb13509.x Pi-Sunyer, 1982, C-terminal octapeptide of cholecystokinin decreases food intake in obese men, Physiol Behav, 29, 627, 10.1016/0031-9384(82)90230-X Primrose, 1989, Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy, Br J Surg, 76, 140, 10.1002/bjs.1800760212 Redding, 1974, Thyroid function in respiratory distress syndrome (RDS) of the newborn, Pediatrics, 54, 423, 10.1542/peds.54.4.423 Reim, 1988, Clinical application of epidermal growth factor in patients with most severe eye burns, Ophthalmologica, 197, 179, 10.1159/000309941 Roberts, 1989, Molecular and functional characterization of amylin, a peptide associated with type II diabetes mellitus, Proc Natl Acad Sei USA, 86, 9662, 10.1073/pnas.86.24.9662 Robinson, 1988, SMS 201-995, a somatostatin analogue, and diarrhea in the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 109, 680, 10.7326/0003-4819-109-8-680 Ross, 1987, Treatment of growth-hormone deficiency with growth hormone-releasing hormone, Lancet, 1, 5, 10.1016/S0140-6736(87)90699-4 Rothmund, 1982, Effect of cimetidine and secretin on acute bleedings from gastroduodenal ulcers and erosions: A prospective study, Dtsch Med Wochenschr, 107, 245, 10.1055/s-2008-1069909 Roy, 1990, A clinical trial of intracavemous vasoactive intestinal peptide to induce penile erection, J Urol, 143, 302, 10.1016/S0022-5347(17)39939-1 Scholar, 1987, The antimetastatic activity of enkephalin-like peptides, Cancer Lett, 35, 133, 10.1016/0304-3835(87)90036-X Shawket, 1991, Prolonged effect of CGRP in Raynaud’s patients: A double-blind randomised comparison with prostacyclin, Br J Clin Pharmacol, 32, 209, 10.1111/j.1365-2125.1991.tb03883.x Shekhar, 1991, Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure, Am J Cardiol, 67, 732, 10.1016/0002-9149(91)90531-O Slapnik, 1992, Intravenous glucagon to dislodge an intestinal foreign body, Am Fam Physician, 45, 55 Smith, 1981, Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat, Science, 213, 1036, 10.1126/science.7268408 Sunderland, 1985, TRH stimulation test in dementia of the Alzheimer type and elderly controls, Psychiatry Res, 16, 269, 10.1016/0165-1781(85)90118-0 Tervo, 1992, Wound healing of the ocular surface, Ann Med, 24, 19, 10.3109/07853899209164141 Trenkner, 1983, Esophageal food impaction: Treatment with glucagon, Radiology, 149, 401, 10.1148/radiology.149.2.6622682 Tympner, 1986, The treatment of chronic recurrent pancreatitis with depot secretin: A preliminary report, Hepatogastroenterology, 33, 159 Usala, 1989, Pharmacology of new hormonal therapies in the treatment of pediatric endocrine disorders, Pediatr Clin North Am, 36, 1157, 10.1016/S0031-3955(16)36763-3 Vinik, 1990, Substance P in neuroendocrine tumors and idiopathic flushing. The value of pentagastrin stimulation tests and the effects of somatostatin analogue, J Clin Endocrinol Metab, 70, 1702, 10.1210/jcem-70-6-1702 Vance, 1990, Growth hormone-releasing hormone, Clin Chem, 36, 415, 10.1093/clinchem/36.3.415 Wakui, 1991, Dramatic recovery from neurological deficits in a patient with central pontine myelinolysis following severe hyponatremia, Jpn J Med, 30, 281, 10.2169/internalmedicine1962.30.281 Walsh, 1981, Gastrointestinal hormones and peptides, 59 Walsh, 1989, Gastrointestinal peptide hormones, 78 Watanabe, 1991, Effect of continuous intravenous infusion of secretin preparation (secrepan) in patients with hemorrhage from chronic peptic ulcer and acute gastric mucosal lesion (AGML), Gastroenterol Jpn, 26, 86, 10.1007/BF02779272 Webb, 1988, Management of foreign bodies of the upper gastrointestinal tract, Gastroenterology, 94, 204, 10.1016/0016-5085(88)90632-4 Whitaker, 1987, Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis, Ann Neurol, 22, 541, 10.1002/ana.410220416 Woltering, 1990, Treatment of nonendocrine gastrointestinal disorders with octreotide acetate, Metabolism, 39, 176, 10.1016/0026-0495(90)90240-D Woltering, 1991, Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane, J Surg Res, 50, 245, 10.1016/0022-4804(91)90186-P Wybran, 1987, Immunologic properties of methionineenkephalin, and therapeutic implications in AIDS, ARC, and cancer, Ann NY Acad Sei, 496, 108, 10.1111/j.1749-6632.1987.tb35753.x Zipf, 1990, Short-term infusion of pancreatic polypeptide: Effect on children with Prader-Willi syndrome, Am J Clin Nutr, 51, 162, 10.1093/ajcn/51.2.162 Zlokovic, 1985, Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotrophin-releasing hormone, Brain Res, 358, 191, 10.1016/0006-8993(85)90963-1